FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Petter Svenberg

Research Profile

Disorders

Procedures

Living Beings

Concepts & Ideas

Chemicals & Drugs

Genes & Molecular Sequences

Genes, T-Cell Receptor delta

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Olle Ringdén; Petter Svenberg; Marie Wikström; Charlotta Edeskog; Britta Eriksson; Sigrun Finnbogadottir; Karin Fransson; Katarina Holmberg; Jonas Mattsson; Ruza Milovsavljevic; Brigitta Omazic; Mats Remberger; Britt-Marie Svahn
Many days at home during neutropenia after allogeneic hematopoietic stem cell transplantation correlates with low incidence of acute graft-versus-host disease.
Sofia Berglund; Jens Gertow; Katarina Le Blanc; Per Ljungman; Mats Remberger; Olle Ringdén; Petter Svenberg; Michael Uhlin; Mehmet Uzunel; Jacek Winiarski; Jonas Mattsson
Factors with an impact on chimerism development and long-term survival after umbilical cord blood transplantation.
Olle Ringdén; Petter Svenberg; Michael Uhlin; Mehmet Uzunel; Göran Dahllöf; Karin Garming-Legert; Helen Karlsson; Mats Remberger; Jonas Mattsson
Sirolimus and tacrolimus as immune prophylaxis compared to cyclosporine with or without methotrexate in patients undergoing allogeneic haematopoietic stem cell transplantation for non-malignant disorders.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Petter Svenberg (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Olle Ringdén; Petter Svenberg; Marie Wikström; Charlotta Edeskog; Britta Eriksson; Sigrun Finnbogadottir; Karin Fransson; Katarina Holmberg; Jonas Mattsson; Ruza Milovsavljevic; Brigitta Omazic; Mats Remberger; Britt-Marie Svahn
Many days at home during neutropenia after allogeneic hematopoietic stem cell transplantation correlates with low incidence of acute graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(2):314-20.
2012: Sofia Berglund; Jens Gertow; Katarina Le Blanc; Per Ljungman; Mats Remberger; Olle Ringdén; Petter Svenberg; Michael Uhlin; Mehmet Uzunel; Jacek Winiarski; Jonas Mattsson
Factors with an impact on chimerism development and long-term survival after umbilical cord blood transplantation.
Transplantation 2012;94(10):1066-74.
2011: Olle Ringdén; Petter Svenberg; Michael Uhlin; Mehmet Uzunel; Göran Dahllöf; Karin Garming-Legert; Helen Karlsson; Mats Remberger; Jonas Mattsson
Sirolimus and tacrolimus as immune prophylaxis compared to cyclosporine with or without methotrexate in patients undergoing allogeneic haematopoietic stem cell transplantation for non-malignant disorders.
European journal of haematology 2011;87(6):503-9.
2009: Petter Svenberg; Jonas Mattsson; Olle Ringdén; Mehmet Uzunel
Allogeneic hematopoietic SCT in patients with non-malignant diseases, and importance of chimerism.
Bone marrow transplantation 2009;44(11):757-63.
2007: Zuzana Hassan; Mats Remberger; Petter Svenberg; Maria Elbander; Brigitta Omazic; Jonas Mattsson; Réka Conrad; Britt-Marie Svahn; Anders Ahlgren; Darius Sairafi; Johan Aschan; Katarina Le Blanc; Lisbeth Barkholt; Olle Ringdén
Hemorrhagic cystitis: a retrospective single-center survey.
Clinical transplantation 2007;21(5):659-67.
2007: Olle Ringdén; Mats Remberger; Petter Svenberg; Britt-Marie Svahn; Göran Dahllöf; B Gustafsson; Zuzana Hassan; Brigitta Omazic; Mehmet Uzunel; Johan Aschan; Lisbeth Barkholt; Jacek Winiarski; Per Ljungman; Jonas Mattsson
Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem cell transplantation for treatment of non-malignant diseases.
Bone marrow transplantation 2007;39(7):383-8.
2006: Olle Ringdén; Petter Svenberg; Katarina Le Blanc; Jonas Mattsson; Mats Remberger
Myeloablative conditioning for hematopoietic stem-cell transplantation in patients with non-malignant diseases.
Bone marrow transplantation 2006;38(4):321-2.
2006: Olle Ringdén; Mats Remberger; Britt-Marie Svahn; Lisbeth Barkholt; Jonas Mattsson; Johan Aschan; Katarina Le Blanc; Britt Gustafsson; Zuzana Hassan; Brigitta Omazic; Petter Svenberg; Göran Solders; Ulrika von Döbeln; Jacek Winiarski; Per Ljungman; Gunilla Malm
Allogeneic hematopoietic stem cell transplantation for inherited disorders: experience in a single center.
Transplantation 2006;81(5):718-25.
2004: Petter Svenberg; Mats Remberger; Johan Svennilson; Jonas Mattsson; Katarina Leblanc; Britt Gustafsson; Johan Aschan; Lisbeth Barkholt; Jacek Winiarski; Per Ljungman; Olle Ringdén
Allogenic stem cell transplantation for nonmalignant disorders using matched unrelated donors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(12):877-82.
2004: Anna Nordlander; Jonas Mattsson; Olle Ringdén; Katarina Leblanc; Britt Gustafsson; Per Ljungman; Petter Svenberg; Johan Svennilson; Mats Remberger
Graft-versus-host disease is associated with a lower relapse incidence after hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(3):195-203.
2000: Henrik Zetterquist; Jonas Mattsson; Mehmet Uzunel; Ingrid Näsman-Björk; Petter Svenberg; L Tammik; G Bayat; Jacek Winiarski; Olle Ringdén
Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia.
Bone marrow transplantation 2000;25(8):843-51.